Gudanar da Goals
"Bi don magance shi" shine manufa ko kusanci wanda ya ci nasara wajen magance wasu cututtuka da yanayi. Dabarun da aka fara amfani dasu don magance hauhawar jini, high cholesterol, da kuma ciwon sukari. Amma, hanyar da aka shimfiɗawa da kuma bi da ita ta ƙaddamar da ita ta haifar da tunaninta ga masana kimiyyar rheumatic .
Dole ne muyi amfani da wannan tsari don samun abubuwa uku:
- manufa
- hanyar yin la'akari idan an buga manufa ko cimma
- Zaɓuɓɓukan maganin da za su iya samun damar ci gaba da manufa
Game da hauhawar jini, binciken da ake ɗaukar karfin jini yana da kasa da 150/100 mm Hg, tare da kasa da 140/90 yana da mahimmanci wajen rage abubuwan da ke faruwa na zuciya. Don cimma burin da ake so don yawan cholesterol da LDL, ana tsara takaddun bayanai. Ga marasa lafiya da ciwon sukari, akwai sharuɗɗa na asibiti don glucose jini da hemoglobin A1C. Abin da ake la'akari da manufa a rheumatology?
Ana bi da su don ci gaba a Rheumatoid Arthritis
A cikin rheumatoid arthritis , babban manufa shine remission . Ƙananan cututtukan ƙwayar cuta ma wata manufa ce, watakila ma mafi mahimmanci kuma mafi mahimmanci a lokuta da yawa. Don buga manufa, ƙonewa dole ne a sarrafawa ko kuma a matsa. An auna wannan ta hanyar yin la'akari da aiki na illa. DAS28 (Cutar Ayyukan Cututtuka) ko CDAI (Clinical Disease Activity Index) suna daga cikin hanyoyin da za a iya gwada aikin cututtuka.
Mafi yawan lokutta na kulawa da aikin kula da cutar ba a ƙayyade ba, amma DAS28 kasa da 2.6 an dauke su a matsayin alamar gyarawa a cikin rashin lafiya na wutsiya na rheumatoid.
Wani muhimmin caveat wanda ba za a manta da shi ba - an yi la'akari da manufofin kulawa. Bayanin rikice-rikice, tarihin maganin miyagun ƙwayoyi, da kuma abin da aka shafi tasoshin ya kamata a la'akari da lokacin da aka tsara hanyar dabara.
Aiki don Target a Lupus
Ƙungiyar aiki ta duniya tana tasowa wani tsari don magance ma'anar lupus . Ƙungiyar aiki ta tabbatar da cewa gyarawa na bayyanar kwayoyin halitta, da kuma tsarin suturar launi na lupus, shine muhimmin magungunan magani ga lupus. Wata mawuyacin da za ta yi niyya ga lupus ya shafi yin rigakafin flares , ciki har da nephritis , neuropsychiatric symptoms, da kuma overall lupus bayyanar cututtuka. Rigakafin lalacewa kuma an kafa shi a matsayin manufa, tare da manufar hana rigakafi da ɓarna ta hanyar kula da cututtukan cututtuka da kuma guba daga magunguna. Sanar da hankali ga rayuwar mai haƙuri yana da mahimmanci.
Ana ci gaba, ma'aikata na da niyya wajen samar da ma'anoni ga sakewa da lupus da kuma aikin rashin lafiya. Har ila yau, akwai buƙata don ƙarin kyan gani.
Yayinda akwai bege ga sababbin magungunan Lupus a nan gaba, an sami cigaba da cigaba da kasuwa don maganin cututtukan jini a shekarar 1998 (lokacin da Enbrel ya zama magungunan kwayar halitta na farko da aka yarda don maganin cututtuka). Game da kwayoyi da ake amfani da su yanzu don magance lupus, ɗawainiyar ma'aikata za su nemi ƙayyade idan akwai ƙananan yanayin steroid waɗanda za a yi la'akari da rashin lafiya a cikin wata hanyar da za a yi amfani da su.
Har ila yau, tambayoyi game da dacewar hydroxychloroquine ga dukan marasa lafiya Lupus yana wanzu.
Bi da don Target don Spondyloarthritis
A shekara ta 2013, masana gwani sunyi la'akari da cewa marasa lafiya tare da spondyloarthritis zasu iya amfanar daga wata yarjejeniyar da za su dace. Sun ƙaddamar da cewa yin la'akari da hakan zai iya amfani da spondyloarthritis amma jagoran kan yadda za a ayyana, aunawa ko ma cimma burin gyarawa ko rashin lafiya ba shi da kyau a cikin wannan cuta. Ba a taɓa samun gwaje-gwajen da za su samo ma'auni mai ƙidayar don aikin cutar a spondyloarthritis. Dole ne a yi aiki. A halin yanzu, an bayar da shawarwari bisa ga shaidar kai tsaye.
Ɗaya daga cikin binciken shine, musamman ga cututtukan cututtuka na psoriatic , idan aka kwatanta da ƙungiyar marasa lafiya da ke kula da daidaitattun kulawa da hanya zuwa wani rukuni wanda ya karbi karin kulawa tare da miyagun ƙwayoyi. A cewar Rheumatology News, ƙungiyar mai tsattsauran ra'ayi ta bi wata yarjejeniya mai kyau kuma idan ba a cika ka'idodin aikin cututtukan ƙananan cuta ba, to, kashi-kashi na hanya ya karu. Har ila yau, idan marasa lafiya sun kasa cika ka'idodin aikin cututtukan cututtuka, an ba su babban haɗin DMARDs . Idan har yanzu ba su cimma wannan manufa ba, an bai wa kungiyar mai mahimmanci TNF . Sakamako ya nuna cewa rukuni mai karfi ya fi mafi girma kungiyar da suka kasance a kan hanya ba tare da wani shiri don rage yawan miyagun ƙwayoyi ba ko kuma maganin cutar.
Har ila yau, a shekara ta Turai na Rheumatology (EULAR 2014), tsawon shekaru biyar da aka gudanar da gwagwarmayar gwagwarmayar Simponi (golimumab) a cikin marasa lafiya da cututtuka na psoriatic ya nuna mafi alhẽri ga magunguna a cikin marasa lafiyar da zasu iya samun ƙananan cututtuka ta hanyar a biyan zuwa manufa m.
Layin Ƙasa
Masu bincike sun gudanar da bincike mai zurfi na wallafe-wallafen kimiyya (Schoels, M. et al.) Game da bi da bi don magance rheumatology. Sun kammala cewa "ƙananan bincike sun yi amfani da ƙayyadaddun hanya don gwada darajar magani ga wani ƙayyadaddun manufa, duk da haka, dukansu sun bayar da shaida mai ƙarfafa na amfanin asibiti na irin wannan hanya. Duk da haka, ana buƙatar ƙarin bayanai game da sakamakon rediyo da aikin kuma marasa lafiya marasa lafiya RA [rheumatoid arthritis] basu samu cikakken bincike ba. "
Hakanan, da ciwon takaddama na musamman, musamman maƙasudin magancewa, yana da hankali. Don sanya wannan a cikin aikin, da manufa ko manufofin dole ne ya zama mafi kyau a tsare don cututtuka na rheumatic.
> Sources:
> 'Bi da zuwa Target': Matsayin Gyara daga Rawanin jini, Hyperlipidaemia da Ciwon sukari zuwa Ritumatoid Arthritis. Dan Atar et al. Annals na Rheumatic Diseases . Afrilu 2010.
> Shaida don maganin cututtukan Arthritis Rheumatoid don Target: Sakamakon bincike na wallafe-wallafe. Schoels M. et al. Annals na Rheumatic Diseases . Afrilu 2010.
> Mahimmanci a kan Lupus Erythematosus: Shawarar Daga Ƙungiyar Ayyukan Ƙasa ta Duniya. Van Vollenhoven RF et al. Annals na Rheumatic Diseases . An wallafa shi a ranar 16 ga Afrilu, 2014.
> Yin maganin Spondyloarthritis, Ciki har da Ankylosing Spondylitis da Arthritis Psoriatic, zuwa Target: Shawarwarin Ƙungiyar Ƙungiyar Ƙasa ta Duniya. Smolen JS et al. Annals na Rheumatic Diseases . Yuni 8, 2013.
> Mahimmancin da ake da shi don maganin ƙwayar cututtukan zuciya na Psoriatic. Rheumatology News . Doug Brunk. Nuwamba 4, 2013.
> Bi da zuwa Target ya nuna Ingantaccen Dama a Psithic Arthritis. Magani na Intanit na Intanit . Jennie Smith. Yuni 12, 2014.